A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%%/tobramycin 0.3%% with dexamethasone 0.1%%/tobramycin 0.3%% in the treatment of Chinese patients with blepharokeratoconjunctivitis

Author： Chen Minjie   Gong Lan   Sun Xinghuai   Gu Yangshun   He Xiangge   Qu Jia   Wang Lili   Zhang Mingzhi   Zhong Xingwu  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.28, Iss.3, 2012-03, pp. : 385-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparison of the safety and efficacy of loteprednol 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of blepharokeratoconjunctivitis

By White Eric M.   Macy Jonathan I.   Bateman Kirk M.   Comstock Timothy L.  

Current Medical Research and Opinion, Vol. 24, Iss. 1, 2008-01 ,pp. : 287-296

Informa Healthcare

Access to resources Recommend Favorite

Tolerability of loteprednol/tobramycin versus dexamethasone/tobramycin in healthy volunteers: results of a 4-week, randomized, double-masked, parallel-group study

By Bartlett Jimmy D.   Holland Edward J.   Usner Dale W.   Paterno Michael R.   Comstock Timothy L.  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2219-2227

Informa Healthcare

Access to resources Recommend Favorite

A randomized, investigator- masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment BID versus QID for the treatment of acute bacterial conjunctivitis of acute bacterial conjunctivitis

By Yee Richard W.   Tepedino Michael   Bernstein Paula   Jensen Harold   Schiffman Rhett   Whitcup Scott M.  

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 425-432

Informa Healthcare

Access to resources Recommend Favorite

Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis

By McCormick Clare   Caballero Armando   Tang Aihua   Balzli Charles   Song Jenny   O'Callaghan Richard  

Current Medical Research and Opinion, Vol. 24, Iss. 6, 2008-06 ,pp. : 1569-1575

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis

By Torkildsen Gail L.   Cockrum Paul   Meier Edward   Hammonds William M.   Silverstein Bruce   Silverstein Steven  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 171-178

Informa Healthcare

Access to resources Recommend Favorite